Where we at?, page-104

First 104 Last

Share
Profile

Follow
TanamiRod

628 Posts.

258

09/04/24

10:53

Post #: 73254411
Share

Originally posted by Mozzarc: ↑

Hahah Ok no essay i promise!
(though you know I could go on and on yeah?)

I think there isn't one single reason, there would be many

If I give you 400 bio stocks and all of them are jumping up and down saying me me me I am the best, my trial patients are fab. Its a tougher decision.

I reckon there has to be an element of us understanding what we have because we HAVE done deep research. That's not just studying google search results. I mean everything to talking to staff and peers and KOLS through to talking to patients and witnessing in the flesh how they were before and how they are now and what it has cost them (side effects and opportunity costs etc). It also plays to understand HOW and WHY the sci works. Whats so special about our drug?

No funds that are really large are going to take such an early punt and even deep research (yet), specially for a co. that is proclaiming the earth on admittedly a lower n. This will come I reckon.

It's too early and our market cap is too small and we need scale..(eg P3)...good step already that we are FT..but we need the next step.

Ok I will post this now, it's already getting essay length? (It doesn't take much).

PS: I still call for negatives...Im not just blind and only want to hear positives, remember this. I just like it when ppl also give credit where it is due....and have a more balanced approach

Expand

Thx Mozz.
Yes, I especially here you on the very last point, that is why I (and a couple of others) am here to balance you out!!

Peace & love.

PAR Price at posting: 32.0¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

JBY

James Bay latest lithium player to pivot to other metals amidst slump

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

I88

Soil sampling extends Portland Creek uranium target by 340% for Infini

There are more pages in this discussion • 603 more messages in this thread...

First 104 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 21.0¢		Change 0.000(0.00%)		Mkt cap ! $73.55M

Open	High	Low	Value	Volume
22.0¢	22.0¢	21.0¢	$68.04K	319.7K

Buyers (Bids)

No.	Vol.	Price($)
6	97644	21.0¢

Sellers (Offers)

Price($)	Vol.	No.
21.5¢	31843	6

View Market Depth

No.	Vol.	Price($)
6	97644	0.210
8	133821	0.205
20	444405	0.200
12	408270	0.195
17	200447	0.190

Price($)	Vol.	No.
0.215	31843	6
0.220	12945	3
0.225	183130	7
0.230	31334	3
0.235	45854	2

Last trade - 10.47am 14/10/2024 (20 minute delay)

PAR (ASX) Chart

Where we at?, page-104

James Bay latest lithium player to pivot to other metals amidst slump

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Soil sampling extends Portland Creek uranium target by 340% for Infini

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Where we at?, page-104

Top Stories

James Bay latest lithium player to pivot to other metals amidst slump

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Soil sampling extends Portland Creek uranium target by 340% for Infini

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News